ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BioFuture 2025 Returns to New York City October 13-15

New Therapeutic Spotlight Series Fosters Meaningful Dialogue Between Innovators, Industry Leaders, Investors, and Potential Partners

In person and virtual registration is now open for Demy-Colton’s BioFuture™ conference, providing leading investors, innovators, industry media, regulators, policymakers and biopharmaceutical companies the strategic insights and powerful relationships needed to lead in the biopharma and healthcare ecosystem.

The conference will take place at Cure in New York City, October 13-15, 2025, and a virtual partnering option is offered October 21-23 including access to the event’s recorded content.

“BioFuture is where today’s brightest minds come together to chart the course of tomorrow’s healthcare,” said Sara Demy, CEO and Founder of Demy-Colton. “We are bringing together the people leading that charge, and this year we’re especially excited to introduce Therapeutic Spotlight Panels, a new way to showcase innovative companies. This new series will shine a light on companies and innovators shaping the future of healthcare in key therapeutic areas such as neuroscience, aging, diagnostics, obesity, cancer and more.”

As noted above, this year’s conference will introduce the Therapeutic Spotlight Series, where innovative biopharma companies will participate in hour-long, focused panel discussions about therapeutic innovations and cutting-edge technologies or advancements that will profoundly change healthcare. Innovative public, private and seed companies are encouraged to submit an application to present at BioFuture as part of a Therapeutic Spotlight Panel or the Seed Showcase. We are seeking biopharma companies developing new therapeutics as well as companies engaged in facilitating the discovery of new therapeutic technologies across biotech, techbio, digital medicine, healthtech, AI, machine learning, big data and healthcare delivery.

Spotlight Panels for Public & Private companies, and presentation slots for Seed companies are available in all therapeutic categories including:

  • Small/large molecule R&D therapeutic
  • Platform
  • Tool
  • Delivery
  • Molecular diagnostic and personalized medicine
  • Research focused service providers
  • Digital Medicine
  • Artificial Intelligence (AI) and Machine Learning (ML)
  • Medical Devices
  • TechBio

For information on presentation or sponsorship opportunities, please contact Lila Taylor at ltaylor@demy-colton.com. For more information about BioFuture or to register, please visit www.biofuture.com and follow #BioFuture2025 on LinkedIn and X for the latest updates and discussions.

About Demy-Colton

Demy-Colton is a leading life sciences and digital health events organization at the forefront of building networks between innovative life sciences companies and industry stakeholders. Its unique events facilitate networking on a global scale, including Biotech Showcase™, BioFuture™, Global Biotech CEO Summit™, Executive Clinics™, and Demy-Colton Virtual Salons™. These events build networking communities that transcend geographical boundaries and establish ongoing, high-value relationships among the industry’s top decision-makers, investors and thought leaders. For more information, visit www.demy-colton.com.

BioFuture is where today’s brightest minds come together to chart the course of tomorrow’s healthcare.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.